SCHEDULE: FMR LLC Reduces Stake in Agilon Health to 3.7%

FMR LLC and Abigail P. Johnson have filed an amendment to their Schedule 13G, reporting a beneficial ownership of 3.7% in Agilon Health Inc.'s common stock.

Summary

• FMR LLC and Abigail P. Johnson, as reporting persons, have filed an Amendment No. 1 to their Schedule 13G regarding their beneficial ownership in AGILON HEALTH INC.
• As of September 30, 2025, FMR LLC and Abigail P. Johnson beneficially own an aggregate of 15,377,531.37 shares of AGILON HEALTH INC. common stock.
• This aggregate amount represents 3.7% of the total outstanding common stock of AGILON HEALTH INC.
• FMR LLC holds sole voting power over 15,374,685.00 shares and sole dispositive power over 15,377,531.37 shares.
• Abigail P. Johnson holds sole dispositive power over 15,377,531.37 shares, with no sole or shared voting power directly attributed.
• The filing indicates that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of the issuer.
• FMR LLC is classified as a parent holding company or control person, and Abigail P. Johnson is an individual.
• Subsidiaries of FMR LLC, including FIAM LLC, Fidelity Management & Research Company LLC, and Strategic Advisers LLC, are identified as investment advisers (IA) that beneficially own shares.

Sentiment

Score: 4

Explanation: The sentiment is slightly negative because a major institutional investor has reduced its stake below the 5% threshold, which can be perceived as a lack of conviction or a strategic divestment.

Negatives

• FMR LLC and Abigail P. Johnson have reduced their beneficial ownership in Agilon Health Inc. to 3.7%, falling below the 5% threshold that typically triggers an initial Schedule 13G filing, indicating a divestment of a portion of their previous holdings.

Future Outlook

This filing is a disclosure of current beneficial ownership and does not contain forward-looking statements or guidance from the issuer or the reporting persons regarding future performance or strategy.

Industry Context

This filing reflects a change in an institutional investor's stake in Agilon Health, a company operating in the healthcare sector. Such changes in significant holdings by major investment firms like FMR LLC are routinely monitored by the market as indicators of investor sentiment towards the company and its industry prospects.

Stakeholder Impact

• Shareholders may view the reduction in FMR LLC's stake as a negative signal, potentially leading to decreased investor confidence or downward pressure on the stock price.
• The company's management might need to address investor concerns regarding the institutional divestment.

Key Dates

Recommendation

A seasoned investor would likely interpret a major institutional investor reducing its stake below the 5% threshold as a negative signal. This could indicate a loss of confidence in the company's future performance or a strategic reallocation of capital away from Agilon Health. While not a definitive 'sell' for all, it warrants a re-evaluation of the investment thesis and could prompt a 'sell' decision, especially if other fundamental indicators are also weakening.

Keywords

Agilon Health Inc., FMR LLC, Abigail P. Johnson, Beneficial Ownership, Schedule 13G, Common Stock, Institutional Investor, Ownership Change, Investment Management